XML 136 R67.htm IDEA: XBRL DOCUMENT v3.25.4
SHAREHOLDERS' EQUITY (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
[1]
Number of Options outstanding    
Beginning balance [1] 1,768,230  
Granted [1] 42,897  
Exercised (505,473)  
Expired and forfeited (48,587)  
Ending balance 1,257,067 1,768,230
Exercisable [1] 1,108,563  
Weighted-Average Exercise Price    
Beginning balance [1] $ 62.9  
Granted [1] 0.87  
Exercised 37.85  
Expired and forfeited 68.5  
Ending balance 70.64 $ 62.9
Exercisable [1] $ 71.39  
Weighted Average Remaining Contractual life, Outstanding 5 years 2 months 1 day 6 years 14 days
Weighted Average Remaining Contractual life, Exercisable [1] 4 years 11 months 4 days  
Aggregate Intrinsic Value, outstanding $ 111,600 $ 305,379
Aggregate Intrinsic Value, exercisable [1] $ 98,545  
[1] Includes 73,074 performance-based options granted to the Company's Co-CEOs in 2022, 74,108 in 2023, 22,481 in 2024 and 20,217 in 2025, as applicable.